| 04/30/2026 4:00 PM | Tevogen Bio (1860871) Filer | Form 10-K/A | |
| 04/22/2026 4:15 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 4:16 PM | Tevogen Bio (1860871) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:04 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:10 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 03/17/2026 3:29 PM | Flomenberg Neal (2011757) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 8:08 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 03/04/2026 8:04 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 8:36 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 02/06/2026 2:09 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/30/2026 2:37 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 01/26/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form DEF 14A | |
| 01/16/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form PRE 14A | |
| 12/30/2025 9:12 AM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/22/2025 4:43 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 7:47 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 12/15/2025 4:31 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 5:51 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 8:22 AM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/14/2025 8:25 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 09/26/2025 4:15 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/26/2025 4:18 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 07/25/2025 6:48 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 07/10/2025 8:18 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 07/10/2025 8:15 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/03/2025 4:23 PM | Tevogen Bio (1860871) Filer | Form 424B5 | |
| 07/03/2025 4:25 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2025 3:48 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 3:49 PM | Flomenberg Neal (2011757) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 3:49 PM | Khan Sadiq (2011764) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 3:49 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2025 4:21 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/27/2025 4:26 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 06/26/2025 11:15 PM | Tevogen Bio (1860871) Filer | Form EFFECT | |
| 06/23/2025 4:06 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/23/2025 4:09 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 06/20/2025 4:20 PM | Tevogen Bio (1860871) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 06/09/2025 6:13 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:45 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/03/2025 12:46 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/03/2025 12:48 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
|
| 05/14/2025 4:27 PM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2025 4:27 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 05/07/2025 4:03 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |